However, tumor cells also express TSPO, and the volumetric analysis showed increased 18F-DPA-714 PET volumes on day 14 at the same level as in the nontreated group because of glioma progression, which may hide possible immunologically induced changes. This evidence concerns the gene TSPO and central nervous system cancer.